Cargando…

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha

BACKGROUND: The ZNF217 gene, encoding a C(2)H(2) zinc finger protein, is located at 20q13 and found amplified and overexpressed in greater than 20% of breast tumors. Current studies indicate ZNF217 drives tumorigenesis, yet the regulatory mechanisms of ZNF217 are largely unknown. Because ZNF217 asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frietze, Seth, O’Geen, Henriette, Littlepage, Laurie E, Simion, Catalina, Sweeney, Colleen A, Farnham, Peggy J, Krig, Sheryl R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082627/ https://www.ncbi.nlm.nih.gov/pubmed/24962896 http://dx.doi.org/10.1186/1471-2164-15-520

Ejemplares similares

ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3′ Ends of ZNF Genes
por: Frietze, Seth, et al.
Publicado: (2010)

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells
por: Krig, Sheryl R., et al.
Publicado: (2010)

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer
por: Umeh-Garcia, Maxine, et al.
Publicado: (2022)

High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling
por: Han, Xiao, et al.
Publicado: (2008)

Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes
por: O'Geen, Henriette, et al.
Publicado: (2010)

Characterization of the Contradictory Chromatin Signatures at the 3′ Exons of Zinc Finger Genes
por: Blahnik, Kimberly R., et al.
Publicado: (2011)

De novo identification of in vivo binding sites from ChIP-chip data
por: Jin, Victor, et al.
Publicado: (2008)

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
por: Amir, Sumaira, et al.
Publicado: (2016)

Genome-Wide Analysis of KAP1 Binding Suggests Autoregulation of KRAB-ZNFs
por: O'Geen, Henriette, et al.
Publicado: (2007)

Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma
por: Briest, Franziska, et al.
Publicado: (2023)

Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells
por: Tak, Yu Gyoung, et al.
Publicado: (2016)

Altering cancer transcriptomes using epigenomic inhibitors
por: Gaddis, Malaina, et al.
Publicado: (2015)

MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015)

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
por: Cohen, Pascale A., et al.
Publicado: (2015)

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression
por: Fahmé, Pia, et al.
Publicado: (2022)

dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression
por: O’Geen, Henriette, et al.
Publicado: (2017)

Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019)

Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine
por: Tiosano, Dov, et al.
Publicado: (2014)

Endogenous mammalian histone H3.3 exhibits chromatin-related functions during development
por: Bush, Kelly M, et al.
Publicado: (2013)

The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance
por: Suarez, Christopher D., et al.
Publicado: (2017)

Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020)

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
por: Fehm, Tanja, et al.
Publicado: (2008)

Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta
por: Liu, Y., et al.
Publicado: (2017)

Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
por: Thiebaut, Charlène, et al.
Publicado: (2017)

Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data
por: Blahnik, Kimberly R., et al.
Publicado: (2010)

Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress
por: Jiang, Xingkang, et al.
Publicado: (2016)

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

Spark: A navigational paradigm for genomic data exploration
por: Nielsen, Cydney B., et al.
Publicado: (2012)

An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
por: Ajj, Hussein, et al.
Publicado: (2013)

SUN-469 Hypothalamic ERalpha Gene Silencing Diminishes Sexual Receptivity in Female Marmoset Monkeys
por: Kraynak, Marissa, et al.
Publicado: (2019)

ZNF143 in Chromatin Looping and Gene Regulation
por: Ye, Bingyu, et al.
Publicado: (2020)

Investigating the effect of visfatin on ERalpha phosphorylation (Ser118 and Ser167) and ERE-dependent transcriptional activity
por: Zangooei, Mohammad, et al.
Publicado: (2018)

ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
por: Thollet, Aurélie, et al.
Publicado: (2010)

Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta-analysis of individual studies
por: Cheng, Ji, et al.
Publicado: (2016)

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer
por: Vendrell, Julie A., et al.
Publicado: (2019)

OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer
por: Guo, Linlin, et al.
Publicado: (2020)

Retracted Article: Berberine alleviates amyloid beta-induced injury in Alzheimer's disease by miR-107/ZNF217
por: Wang, Jing, et al.
Publicado: (2019)

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX(®) Recurrence Score in ER-Positive Invasive Breast Cancers
por: Cohen, Pascale A., et al.
Publicado: (2019)

A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
por: O'Geen, Henriette, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i99oi8tsl1jivhvop9lm1bluea